L-Theanine in the Adjunctive Treatment of Generalised Anxiety Disorder:A Double-Blind Randomised Placebo-Controlled Trial (TAGS)
收藏Research Data Australia2025-12-20 收录
下载链接：
https://researchdata.edu.au/l-theanine-adjunctive-trial-tags/3491244
下载链接
链接失效反馈官方服务：
资源简介：
The objective of this trial is to assess the effectiveness and safety of L-theanine (an amino acid constituent of green tea [Camellia sinensis]) as an adjunctive therapy to treat GAD by conducting a phase II double-blind randomised controlled trial. It is hypothesised that L-theanine will be superior to placebo in reducing anxiety in participants with GAD.
The dataset relates to the clinical trial ACTRN12616000759493 L-Theanine in the Adjunctive Treatment of Generalised Anxiety Disorder:
A Double-Blind Randomised Placebo-Controlled Trial.
This data cannot be shared publicly due to ethics approval conditions.
To discuss this data, please contact the NICM Health Research Institute nicm@westernsydney.edu.au.
提供机构：
Western Sydney University
